Concepedia
8
Publications
182
Citations
H-Index
2016
Active since
Affiliations
University of Colorado Anschutz Medical Campus(Current)
University of Colorado Cancer Center
University of Colorado Denver
The University of Texas at Austin
National Cancer Centre Singapore
Anna Schreiber is an author at University of Colorado Anschutz Medical Campus.
Publications per year
2016–2024
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms
Aaron J. Scott, John J. Arcaroli, Stacey M. Bagby et al. · Molecular Cancer Therapeutics · 2018 · 44 citations · Full text
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance
Kevin S. Quackenbush, Stacey M. Bagby, Wai Meng David Tai et al. · Oncotarget · 2016 · 39 citations · Full text
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
Stephen G. Smoots, Anna Schreiber, Marilyn M. Jackson et al. · Breast Cancer Research · 2024 · 23 citations · Full text
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy
Justin Greene, Anna Nguyen, Stacey M. Bagby et al. · Oncotarget · 2017 · 22 citations · Full text
Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials
Anna Schreiber, Jodi Kagihara, Jennifer Weiss et al. · Frontiers in Oncology · 2021 · 20 citations · Full text
Rows per page
1–5 of 8